4//SEC Filing
Robichaud Albert 4
Accession 0001562180-20-001244
CIK 0001597553other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:57 PM ET
Size
7.7 KB
Accession
0001562180-20-001244
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-12+20,000→ 20,000 totalExercise: $68.87Exp: 2030-02-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The securities awarded on February 12, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of February 12, 2020, with 15,000 shares vesting in 36 equal monthly installments thereafter.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:57 PM ET
- Size
- 7.7 KB